Pfizer

News

Pfizer joins Lilly in direct-to-consumer drive

Pfizer has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access.

News

New COVID-19 jabs approved by FDA for 2024-25 season

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in r

News

Adcendo licenses Multitude anti-TF ADC in $1bn+ deal

Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in variou

News

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight.

News

Pfizer grows digital team with chief AI officer appointment

Pfizer has appointed Berta Rodriguez-Hervas to its digital leadership team, naming her chief artificial intelligence and analytics officer.

News

NICE updates on controversial multiple myeloma decisions

NICE has defended a trio of decisions on new therapies for multiple myeloma, which saw two drugs approved for restricted use in England and Wales and a third turned down altogether.

Pfizer joins Lilly in direct-to-consumer drive

New COVID-19 jabs approved by FDA for 2024-25 season

Adcendo licenses Multitude anti-TF ADC in $1bn+ deal

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer grows digital team with chief AI officer appointment

NICE updates on controversial multiple myeloma decisions

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks